MEDICARE PART D

We cover prescription drug benefits in accordance with Medicare Part D under multiple contracts with the Centers for Medicare and Medicaid Services, or CMS, as described in Note 2 to the consolidated financial statements included in our 2014 Form 10-K. The accompanying condensed consolidated balance sheets include the following amounts associated with Medicare Part D at June 30, 2015 and December 31, 2014. CMS subsidies/discounts in the table below include the reinsurance and low-income cost subsidies funded by CMS for which we assume no risk as well as brand name prescription drug discounts for Part D plan participants in the coverage gap funded by CMS and pharmaceutical manufacturers. The risk corridor settlement includes amounts classified as long-term because settlement associated with the 2015 provision will exceed 12 months at June 30, 2015.



	June 30, 2015						December 31, 2014
	Risk Corridor Settlement			CMS Subsidies/ Discounts			Risk Corridor Settlement			CMS Subsidies/ Discounts
	(in millions)
Other current assets	$	105		$	2,104		$	105		$	1,690
Trade accounts payable and accrued expenses	(23		)	(176		)	(36		)	(32		)
Net current asset	82			1,928			69			1,658
Other long-term assets	121			—			—			—
Other long-term liabilities	(18		)	—			—			—
Net long-term asset	103			—			—			—
Total net asset	$	185		$	1,928		$	69		$	1,658